AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8851775 — intervention group
Group type: EXPERIMENTAL
Intervention: Still photographs of real-world scenes
Number of subjects: 0
Study 2180458 — intervention group
Group type: EXPERIMENTAL
Intervention: Capitation system
Number of subjects: 0
Study 2180458 — intervention group
Group type: COMPARATOR
Intervention: Fee-for-service system
Number of subjects: 0
Study 2180458 — intervention group
Group type: COMPARATOR
Intervention: Both systems
Number of subjects: 0
Study 6767404 — intervention group
Group type: EXPERIMENTAL
Intervention: Mestranol 50 micrograms and norethindrone 1 mg
Number of subjects: 100
Study 6767404 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol 50 micrograms and norethindrone 1 mg
Number of subjects: 100
Study 6767404 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol 35 micrograms and norethindrone 1 mg
Number of subjects: 100
Study 6767404 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol 30 micrograms and levonorgestrel 150 mg
Number of subjects: 100
Study 6767404 — intervention group
Group type: COMPARATOR
Intervention: Contraceptive vaginal ring (CVR) containing levonorgestrel and estradiol
Number of subjects: 100
Study 30199738 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory Flexibility (MemFlex) training
Number of subjects: 60
Study 30199738 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation (Control)
Number of subjects: 60
Study 25810426 — intervention group
Group type: EXPERIMENTAL
Intervention: Discordant participants with high perceived balance and low measured balance
Number of subjects: 352
Study 25810426 — intervention group
Group type: EXPERIMENTAL
Intervention: Discordant participants with low perceived balance and high measured balance
Number of subjects: 352
Study 25810426 — intervention group
Group type: EXPERIMENTAL
Intervention: Concordant participants with high perceived and measured balance
Number of subjects: 352
Study 24926949 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 IU of oral vitamin D2 daily (Arm A)
Number of subjects: 63
Study 24926949 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 IU daily in summer/fall and 2000 IU in winter/spring (Arm B)
Number of subjects: 63
Study 23441533 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin treatment
Number of subjects: 62
Study 23441533 — intervention group
Group type: COMPARATOR
Intervention: Other treatments for renal anemia
Number of subjects: 62
Study 20212395 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized L‐epinephrine (LE)
Number of subjects: 64
Study 20212395 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate (BD) 200 mg
Number of subjects: 64
Study 20212395 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular dexamethasone (D) 0.6 mg/kg
Number of subjects: 64
Study 18411237 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose naloxone infusion (0.25 microg/kg per hour)
Number of subjects: 82
Study 18411237 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 82
Study 16364244 — intervention group
Group type: EXPERIMENTAL
Intervention: ND4 G11696A mutation
Number of subjects: 5
Study 16364244 — intervention group
Group type: EXPERIMENTAL
Intervention: N405D in the ND5 and G5820A in the tRNA(Cys)
Number of subjects: 5
Study 16364244 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of functionally significant mtDNA mutations
Number of subjects: 5
Study 12552209 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% hyperbaric lidocaine
Number of subjects: 453
Study 12552209 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% hyperbaric lidocaine
Number of subjects: 453
Study 12552209 — intervention group
Group type: EXPERIMENTAL
Intervention: TNS present
Number of subjects: 453
Study 12552209 — intervention group
Group type: EXPERIMENTAL
Intervention: TNS absent
Number of subjects: 453
Study 12552209 — intervention group
Group type: EXPERIMENTAL
Intervention: TNS patients
Number of subjects: 453
Study 10591360 — intervention group
Group type: EXPERIMENTAL
Intervention: ramosetron 0.3 mg
Number of subjects: 100
Study 10591360 — intervention group
Group type: COMPARATOR
Intervention: granisetron 3 mg
Number of subjects: 100
Study 9360939 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacterial lysate treatment for three months
Number of subjects: 11
Study 9360939 — intervention group
Group type: COMPARATOR
Intervention: Control group (N=10)
Number of subjects: 11
Study 1942929 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarterial administration of cisplatinum
Number of subjects: 118
Study 1942929 — intervention group
Group type: COMPARATOR
Intervention: Intravenous administration of cisplatinum
Number of subjects: 118
Study 1942929 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall response rate for all patients
Number of subjects: 118
Study 1942929 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall metastasis free survival (MFS)
Number of subjects: 118
Study 7461024 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg oral digoxin
Number of subjects: 9
Study 7461024 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg oral digoxin
Number of subjects: 9
Study 7461024 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg oral digoxin
Number of subjects: 9
Study 7461024 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg oral digoxin
Number of subjects: 9
Study 7461024 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 mg oral digoxin
Number of subjects: 9
Study 7461024 — intervention group
Group type: EXPERIMENTAL
Intervention: All doses
Number of subjects: 9
Study 31317459 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (LAP)
Number of subjects: 256
Study 31317459 — intervention group
Group type: COMPARATOR
Intervention: Open surgery (OPEN)
Number of subjects: 256
Study 30962499 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary magnesium intake
Number of subjects: 1050
Study 30962499 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) level
Number of subjects: 1050
Study 30962499 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin-6 (IL-6)
Number of subjects: 1050
Study 30962499 — intervention group
Group type: EXPERIMENTAL
Intervention: Path analysis of dietary magnesium
Number of subjects: 1050
Study 27837273 — intervention group
Group type: EXPERIMENTAL
Intervention: ONSTEP technique
Number of subjects: 290
Study 27837273 — intervention group
Group type: COMPARATOR
Intervention: Lichtenstein technique
Number of subjects: 290
Study 27837273 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 290
Study 25532675 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegan diet
Number of subjects: 61
Study 25532675 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetarian diet
Number of subjects: 61
Study 25532675 — intervention group
Group type: EXPERIMENTAL
Intervention: Pescovegetarian diet
Number of subjects: 61
Study 25532675 — intervention group
Group type: COMPARATOR
Intervention: Semivegetarian diet
Number of subjects: 61
Study 25532675 — intervention group
Group type: COMPARATOR
Intervention: Omnivorous diet
Number of subjects: 61
Study 23652826 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (simvastatin 40 mg and ezetimibe 10 mg daily)
Number of subjects: 15
Study 23652826 — intervention group
Group type: COMPARATOR
Intervention: Statin monotherapy (simvastatin 40 mg daily)
Number of subjects: 15
Study 21722832 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional open surgical repair
Number of subjects: 0
Study 21722832 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment
Number of subjects: 0
Study 21722832 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid technique
Number of subjects: 0
Study 21722832 — intervention group
Group type: EXPERIMENTAL
Intervention: Refinements in open surgical techniques and branched endovascular graft repair
Number of subjects: 0
Study 21722832 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid techniques
Number of subjects: 0
Study 21722832 — intervention group
Group type: EXPERIMENTAL
Intervention: Circumstantial evidence
Number of subjects: 0
Study 19758522 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide
Number of subjects: 20
Study 19758522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 17211442 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfuzosin 10 mg once daily
Number of subjects: 372
Study 17211442 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372
Study 15135704 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide
Number of subjects: 0
Study 15135704 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban HCl
Number of subjects: 0
Study 11282752 — intervention group
Group type: EXPERIMENTAL
Intervention: ESAT-6-specific IFN-gamma-secreting T cells
Number of subjects: 146
Study 11282752 — intervention group
Group type: COMPARATOR
Intervention: Diagnostic tuberculin skin test (TST)
Number of subjects: 146
Study 11282752 — intervention group
Group type: EXPERIMENTAL
Intervention: ESAT-6-specific T cells
Number of subjects: 146
Study 11282752 — intervention group
Group type: COMPARATOR
Intervention: Unexposed BCG-vaccinated subjects
Number of subjects: 146
Study 9644529 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefodizime (modivid) used prophylactically in cholecystectomy
Number of subjects: 0
Study 9644529 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefodizime (modivid)
Number of subjects: 0
Study 7943118 — intervention group
Group type: EXPERIMENTAL
Intervention: Troxerutin
Number of subjects: 53
Study 7943118 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 3075441 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine-sulphadoxine-pyrimethamine (MSP, Fansimef)
Number of subjects: 0
Study 3075441 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 0
Study 3075441 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine
Number of subjects: 0
Study 31506338 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 6
Study 31506338 — intervention group
Group type: COMPARATOR
Intervention: Lateral decubitus position
Number of subjects: 6
Study 27736028 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous and intracoronary melatonin
Number of subjects: 146
Study 26557623 — intervention group
Group type: EXPERIMENTAL
Intervention: Various sensory input methods (multisensory approach)
Number of subjects: 200
Study 26557623 — intervention group
Group type: COMPARATOR
Intervention: Unisensory method
Number of subjects: 200
Study 24167976 — intervention group
Group type: EXPERIMENTAL
Intervention: Hochuekkito (TJ‐41) 7.5 g/day for 7 days before surgery
Number of subjects: 48
Study 24167976 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 48
Study 21804670 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐Flex
Number of subjects: 168
Study 21804670 — intervention group
Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 168
Study 21804670 — intervention group
Group type: COMPARATOR
Intervention: APAP (switched to CPAP at fixed pressure)
Number of subjects: 168
Study 19394009 — intervention group
Group type: EXPERIMENTAL
Intervention: Autofluorescence imaging
Number of subjects: 0
Study 19394009 — intervention group
Group type: COMPARATOR
Intervention: White-light endoscopy
Number of subjects: 0
Study 19468545 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron (4 mg)
Number of subjects: 100
Study 19468545 — intervention group
Group type: EXPERIMENTAL
Intervention: metoclopramide (10 mg)
Number of subjects: 100
Study 19468545 — intervention group
Group type: EXPERIMENTAL
Intervention: droperidol (1.25 mg)
Number of subjects: 100
Study 19468545 — intervention group
Group type: EXPERIMENTAL
Intervention: dexametasone (8 mg)
Number of subjects: 100
Study 19468545 — intervention group
Group type: COMPARATOR
Intervention: Control group (no medication)
Number of subjects: 100
Study 15059263 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 11701101 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar spine radiography and usual care
Number of subjects: 476
Study 11701101 — intervention group
Group type: COMPARATOR
Intervention: Usual care without radiography
Number of subjects: 476
Study 9466094 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (2 mg kg‐1 h‐1)
Number of subjects: 45
Study 9466094 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.06 mg kg‐1 h‐1)
Number of subjects: 45
Study 9466094 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma-hydroxybutyrate (20 mg kg‐1 h‐1)
Number of subjects: 45
Study 7955138 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural management approach to treating sleeping problems
Number of subjects: 0
Study 7955138 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0
Study 3667022 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose (81 +/- 18 g)
Number of subjects: 5
Study 3667022 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (384 +/- 13 mg)
Number of subjects: 5
Study 3667022 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose (72 +/- 22 g) plus caffeine (396 +/- 29 mg)
Number of subjects: 5
Study 3667022 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 5
Study 3667022 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose plus caffeine
Number of subjects: 5
Study 3667022 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose
Number of subjects: 5
Study 3667022 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 5
Study 3667022 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 5
Study 29421772 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (CQ10) supplementation 100 mg/d for 12 weeks
Number of subjects: 40
Study 29421772 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 26694632 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chamomile gel applied twice daily for 1 month
Number of subjects: 62
Study 26694632 — intervention group
Group type: COMPARATOR
Intervention: Placebo applied twice daily for 1 month
Number of subjects: 62
Study 24462464 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin plus oral vinorelbine plus cisplatin
Number of subjects: 66
Study 24462464 — intervention group
Group type: COMPARATOR
Intervention: Oral vinorelbine plus cisplatin alone (placebo)
Number of subjects: 66
Study 24462464 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Nitroglycerin and Control)
Number of subjects: 66
Study 23773411 — intervention group
Group type: EXPERIMENTAL
Intervention: RT+CON (radiotherapy with carbogen and nicotinamide)
Number of subjects: 231
Study 23773411 — intervention group
Group type: COMPARATOR
Intervention: RT (radiotherapy alone)
Number of subjects: 231
Study 23773411 — intervention group
Group type: EXPERIMENTAL
Intervention: RT+CON versus RT
Number of subjects: 231
Study 20006908 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectacles plus patching >or=8 hours daily 6 days a week
Number of subjects: 40
Study 20006908 — intervention group
Group type: COMPARATOR
Intervention: Spectacles plus patching >or=8 hours on alternate days
Number of subjects: 40
Study 20006908 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (daily and alternate-day occlusion)
Number of subjects: 40
Study 19057729 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative autologous blood donation (Group B)
Number of subjects: 48
Study 19057729 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group A)
Number of subjects: 48
Study 17086005 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress testing with blinded troponins
Number of subjects: 241
Study 17086005 — intervention group
Group type: COMPARATOR
Intervention: Troponin I-guided strategy
Number of subjects: 241
Study 12954744 — intervention group
Group type: EXPERIMENTAL
Intervention: High-saturation group (target functional oxygen-saturation range of 95 to 98 percent)
Number of subjects: 358
Study 12954744 — intervention group
Group type: COMPARATOR
Intervention: Standard-saturation group (target functional oxygen-saturation range of 91 to 94 percent)
Number of subjects: 358
Study 12954744 — intervention group
Group type: EXPERIMENTAL
Intervention: High-saturation group
Number of subjects: 358
Study 12954744 — intervention group
Group type: COMPARATOR
Intervention: Standard-saturation group
Number of subjects: 358
Study 11532470 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdeletions of the long arm of chromosome Y (AZFa, AZFb, AZFc)
Number of subjects: 54
Study 11532470 — intervention group
Group type: EXPERIMENTAL
Intervention: Semen analysis and hormonal measurements (FSH, LH, testosterone, prolactin, estradiol)
Number of subjects: 54
Study 9489595 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine delivered over 40 seconds with a 5 min lockout interval
Number of subjects: 40
Study 9489595 — intervention group
Group type: COMPARATOR
Intervention: Morphine delivered over 5 minutes with a 1 min lockout interval
Number of subjects: 40
Study 7827744 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) twice weekly for one hour each session
Number of subjects: 22
Study 7827744 — intervention group
Group type: COMPARATOR
Intervention: Control group (local wound care followed by application of an Unna boot)
Number of subjects: 22
Study 3413461 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg slow-release pindolol once daily
Number of subjects: 12
Study 3413461 — intervention group
Group type: COMPARATOR
Intervention: 5 mg pindolol three times daily
Number of subjects: 12
Study 31701483 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia Care Mapping™ (DCM)
Number of subjects: 726
Study 31701483 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 726
Study 29297980 — intervention group
Group type: EXPERIMENTAL
Intervention: ledipasvir-sofosbuvir
Number of subjects: 239
Study 29297980 — intervention group
Group type: COMPARATOR
Intervention: sofosbuvir + ribavirin
Number of subjects: 239
Study 28441068 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐NAC eye drops (1 instillation in 1 eye)
Number of subjects: 38
Study 28441068 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐NAC eye drops (QD or BID for 5 days)
Number of subjects: 38
Study 28441068 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline solution)
Number of subjects: 38
Study 28441068 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐NAC eye drops (both cohorts)
Number of subjects: 38
Study 26220179 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Tape (KT) applied to quadriceps muscles
Number of subjects: 24
Study 26220179 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation program
Number of subjects: 24
Study 20616787 — intervention group
Group type: EXPERIMENTAL
Intervention: Watermelon supplementation (L-citrulline/L-arginine, 2.7 g/1.3 g/day)
Number of subjects: 9
Study 20616787 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 18221288 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg udenafil
Number of subjects: 167
Study 18221288 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg udenafil
Number of subjects: 167
Study 18221288 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study 17212078 — intervention group
Group type: EXPERIMENTAL
Intervention: ART (Atraumatic Restorative Treatment)
Number of subjects: 157
Study 17212078 — intervention group
Group type: COMPARATOR
Intervention: Conventional cavity preparation
Number of subjects: 157
Study 14719760 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etch adhesive (Clearfil SE Bond)
Number of subjects: 66
Study 14719760 — intervention group
Group type: COMPARATOR
Intervention: Total-etch adhesive (Prime & Bond NT)
Number of subjects: 66
Study 10925662 — intervention group
Group type: EXPERIMENTAL
Intervention: EHF therapy + magnetotherapy + drugs
Number of subjects: 0
Study 10925662 — intervention group
Group type: COMPARATOR
Intervention: Standard drug therapy
Number of subjects: 0
Study 8930569 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactose-restricted diet for 6 weeks
Number of subjects: 105
Study 8930569 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 105
Study 14621839 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 pulses of 8 mg/kg methylprednisolone (MPS) in an alternate‐day regimen (total dose 25 mg/kg in 1 week)
Number of subjects: 46
Study 14621839 — intervention group
Group type: COMPARATOR
Intervention: 5 daily pulses of 3 mg/kg MPS (total dose 17 mg/kg)
Number of subjects: 46
Study 31820806 — intervention group
Group type: EXPERIMENTAL
Intervention: Nodule excision
Number of subjects: 60
Study 31820806 — intervention group
Group type: COMPARATOR
Intervention: Segmental resection
Number of subjects: 60
Study 31820806 — intervention group
Group type: EXPERIMENTAL
Intervention: Nodule excision and Segmental resection
Number of subjects: 60
Study 29898058 — intervention group
Group type: EXPERIMENTAL
Intervention: In-office bleaching with 38% peroxide hydrogen followed by a second in-office session
Number of subjects: 40
Study 29898058 — intervention group
Group type: COMPARATOR
Intervention: In-office bleaching with 38% peroxide hydrogen followed by at-home bleaching with 10% carbamide peroxide for 7 days
Number of subjects: 40
Study 26861445 — intervention group
Group type: EXPERIMENTAL
Intervention: Advergame promoting energy-dense snacks
Number of subjects: 0
Study 26861445 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no advergame)
Number of subjects: 0
Study 24454918 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 262
Study 24454918 — intervention group
Group type: EXPERIMENTAL
Intervention: RMS ECG
Number of subjects: 262
Study 24454918 — intervention group
Group type: EXPERIMENTAL
Intervention: LQT-2
Number of subjects: 262
Study 24454918 — intervention group
Group type: EXPERIMENTAL
Intervention: LQT-1 and LQT-3
Number of subjects: 262
Study 24454918 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 262
Study 22818724 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Cognitive Theory-based counseling paired with technology-based self-monitoring
Number of subjects: 296
Study 22818724 — intervention group
Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 296
Study 20571361 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative hypothermia (33.3 degrees +/- 0.8 degrees C)
Number of subjects: 1000